These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
739 related items for PubMed ID: 15055140
1. [Antimicrobial prophylaxis and therapy in neutropenia]. Link H. Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140 [Abstract] [Full Text] [Related]
4. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia]. Jarque I, Sanz MA. Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194 [Abstract] [Full Text] [Related]
5. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy? Klastersky J. J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173 [Abstract] [Full Text] [Related]
6. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M. Clin Infect Dis; 2009 Apr 15; 48(8):1042-51. PubMed ID: 19281327 [Abstract] [Full Text] [Related]
7. Antibiotic use in neonatal sepsis. Yurdakök M. Turk J Pediatr; 1998 Apr 15; 40(1):17-33. PubMed ID: 9722468 [Abstract] [Full Text] [Related]
11. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany. J Antimicrob Chemother; 2006 Feb 15; 57(2):317-25. PubMed ID: 16339606 [Abstract] [Full Text] [Related]
12. [Management of febrile neutropenic patients]. Takata T, Tamura K. Gan To Kagaku Ryoho; 2006 Jan 15; 33(1):13-8. PubMed ID: 16410691 [Abstract] [Full Text] [Related]
15. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W. Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812 [Abstract] [Full Text] [Related]
16. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Bennett JE, Powers J, Walsh T, Viscoli C, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Verweij P. Clin Infect Dis; 2003 Apr 15; 36(Suppl 3):S117-22. PubMed ID: 12679895 [Abstract] [Full Text] [Related]
18. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here? Pizzo PA. J Antimicrob Chemother; 2009 May 15; 63 Suppl 1():i16-7. PubMed ID: 19372174 [Abstract] [Full Text] [Related]
20. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. Qin TJ, Mi YC, Feng SZ, Li DP, Wei JL, Yang DL, Han MZ, Wang JX, Bian SG. Zhonghua Yi Xue Za Zhi; 2007 May 29; 87(20):1389-93. PubMed ID: 17785058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]